Open AccessEfficacy of a CDK 4/6 inhibitor combined with an aromatase inhibitor as a first line treatment in the case of advanced breast cancer HR+/HER2-
Author(s) -
Andreea Lazescu,
Marius Pirciu,
Elena Avram,
Adelina Gheorghe,
Elena Dumitrescu,
Oana Trifănescu,
Dana Lucia Stănculeanu
Publication year - 2022
Publication title -
book of abstracts
Language(s) - English
Resource type - Conference proceedings
DOI - 10.21175/rad.spr.abstr.book.2022.20.4
Subject(s) - aromatase inhibitor , cdk inhibitor , cyclin dependent kinase , breast cancer , aromatase , mek inhibitor , cancer research , pharmacology , medicine , cancer , oncology , kinase , chemistry , cell cycle , mapk/erk pathway , biochemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom